{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:21:17Z","timestamp":1761675677922},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.contraception.2009.03.020","type":"journal-article","created":{"date-parts":[[2009,5,24]],"date-time":"2009-05-24T08:24:39Z","timestamp":1243153479000},"page":"484-492","source":"Crossref","is-referenced-by-count":10,"title":["A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom\u00ae formulations in women from Cameroon"],"prefix":"10.1016","volume":"80","author":[{"given":"Francois-Xavier","family":"Mbopi-Keou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabeea F.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngoh N.","family":"Nkele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9raphin","family":"Fokoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enow R.","family":"Mbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Giguere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Christian","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyne","family":"Piret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Landry","family":"Tsague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopold","family":"Zekeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Mwatha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"M\u00e2sse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel G.","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.03.020_bib1","author":"WHO"},{"key":"10.1016\/j.contraception.2009.03.020_bib2","author":"WHO"},{"key":"10.1016\/j.contraception.2009.03.020_bib3","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)"},{"key":"10.1016\/j.contraception.2009.03.020_bib4","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1097\/QAD.0b013e3282f006c3","article-title":"High impact of mobile units for mass HIV testing in Africa","volume":"21","author":"Mbopi-K\u00e9ou","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2009.03.020_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(07)60202-5","article-title":"Microbicides drug candidates to prevent HIV infection","volume":"369","author":"Balzarini","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.03.020_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/108729102760330263","article-title":"Microbicides 2002: an update","volume":"16","author":"Johnston","year":"2002","journal-title":"AIDS Patient Care and STDs"},{"key":"10.1016\/j.contraception.2009.03.020_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(07)60285-2","article-title":"Newer approaches to HIV prevention","volume":"369","author":"Editorial","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2009.03.020_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00007435-200108000-00012","article-title":"Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and herpes simplex virus type 2","volume":"28","author":"Piret","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.contraception.2009.03.020_bib9","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/AAC.45.8.2229-2237.2001","article-title":"Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment","volume":"45","author":"Bestman-Smith","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.contraception.2009.03.020_bib10","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.46.9.2933-2942.2002","article-title":"Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine","volume":"46","author":"Piret","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.contraception.2009.03.020_bib11","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/AAC.45.6.1671-1681.2001","article-title":"Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases","volume":"45","author":"Roy","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.contraception.2009.03.020_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.43.2.314","article-title":"A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses","volume":"43","author":"Howett","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.contraception.2009.03.020_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1095\/biolreprod.102.014043","article-title":"Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device","volume":"69","author":"Haineault","year":"2003","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2009.03.020_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jat.1262","article-title":"Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models","volume":"28","author":"Piret","year":"2008","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.contraception.2009.03.020_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2007.04.015","article-title":"Safety, tolerance and acceptability of the Invisible Condom\u00ae and its vaginal applicator in healthy women and their male sexual partners","volume":"76","author":"Trottier","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.020_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.contraception.2008.01.015","article-title":"Distribution of a vaginal gel (Invisible Condom\u00ae) before, during and after simulated sexual intercourse and its persistence when delivered by 2 different vaginal applicators: a magnetic resonance imaging (MRI) study","volume":"77","author":"Omar","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.020_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/aid.2005.21.845","article-title":"In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials","volume":"21","author":"Tien","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.contraception.2009.03.020_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.contraception.2006.09.003","article-title":"Fourteen-day safety and acceptability study of the universal placebo gel","volume":"75","author":"Schwartz","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.020_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","article-title":"Reliability of diagnosis bacterial vaginosis is improved by a standardized method of Gram Stain interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.contraception.2009.03.020_bib20","series-title":"Manual for the standarisation of colposcopy for the evaluation of vaginal products","author":"World Health Organization (WHO)\/Contraceptive Research and Development Program (CONRAD)","year":"2004"},{"key":"10.1016\/j.contraception.2009.03.020_bib21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/infdis\/165.6.1142","article-title":"Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9","volume":"165","author":"McGroarty","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.contraception.2009.03.020_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Non-specific vaginitis","volume":"74","author":"Amsel","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2009.03.020_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00006250-199203000-00003","article-title":"The Bethesda classification for squamous intraepithelial lesions: histologic, cytologic and viral correlates","volume":"79","author":"Tabbara","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.020_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00007435-199903000-00009","article-title":"Protective effect of a thermoreversible formulation against the toxicity of nonoxynol-9","volume":"26","author":"Gagn\u00e9","year":"1999","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.contraception.2009.03.020_bib25","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.2174\/138161205774580633","article-title":"Microbicides for prevention of transmission of sexually transmitted diseases","volume":"11","author":"Howett","year":"2005","journal-title":"Curr Pharm Design"},{"key":"10.1016\/j.contraception.2009.03.020_bib26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jps.20752","article-title":"Temperature and pH sensitive smart hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles","volume":"96","author":"Gupta","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.contraception.2009.03.020_bib27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.aids.0000226950.72223.5f","article-title":"Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women","volume":"20","author":"El-Sadr","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2009.03.020_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.aids.0000210608.70762.c3","article-title":"HPTN 050 Protocol Team. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women","volume":"20","author":"Mayer","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2009.03.020_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/318496","article-title":"Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States","volume":"32","author":"Mayer","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.contraception.2009.03.020_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-6405-3-4","article-title":"HIV Prevention Trial Network (HPTN) 047 Protocol Team. Phase I safety study of 0.5% PRO 2000 vaginal gel among HIV un-infected women in Pune, India","volume":"3","author":"Joshi","year":"2006","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.contraception.2009.03.020_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.qai.0000243056.59860.c1","article-title":"Safety and acceptability of the candidate microbicides Carraguard in Thai women","volume":"43","author":"Kilmarx","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2009.03.020_bib32","first-page":"262","article-title":"Adhesion of poloxamer 407 formulations on dog ileal segments in vitro","volume":"37","author":"Juhasz","year":"1991","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T17:45:16Z","timestamp":1589823916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0010782409001152"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.03.020","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}